Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4
ConditionCancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInstitut Curie
About this trial
Multi-cohort exploratory prospective study. Participation in the ALCINA 4 study does not change the standard management of the patient, including the treatments administered. A sampling schedule will be set up for each cohort.
Depending on the clinical context studied and the biomarkers studied and/or sought, the timing of blood samples will vary between cohorts. There may be up to 4 samples (or more) taken per patient for up to 18, 24 or 36 months. If a specific tumor sample is required, it will be collected only once during the study.
Eligibility criteria
Qualifiers
Patient treated for cancer at one of the participating center
18 years old or higher
Signed informed consent form
Patient not deprived of their liberty or under guardianship (including temporary guardianship)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Blood sample
- Biopsy
Treatment groups
2,050 Participants
are divided into 12 treatment groups12
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Source ClinicalTrials.gov